Patents by Inventor Scott Bruder

Scott Bruder has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines
    Publication number: 20170252375
    Abstract: The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
    Type: Application
    Filed: March 27, 2017
    Publication date: September 7, 2017
    Inventors: Mohamed Attawia, Thomas M. DiMauro, Hassan Serhan, Sudhakar Kadiyala, David Urbahns, Scott Bruder
  • Transdiscal Administration of Specific Inhibitors of Pro-Inflammatory Cytokines
    Publication number: 20170065641
    Abstract: The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
    Type: Application
    Filed: October 28, 2016
    Publication date: March 9, 2017
    Inventors: Mohamed Attawia, Thomas M. DiMauro, Hassan Serhan, Sudhakar Kadiyala, David Urbahns, Scott Bruder
  • Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines
    Publication number: 20160310573
    Abstract: The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
    Type: Application
    Filed: July 1, 2016
    Publication date: October 27, 2016
    Inventors: Mohamed Attawia, Thomas M. DiMauro, Hassan Serhan, Sudhakar Kadiyala, David Urbahns, Scott Bruder
  • Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines
    Publication number: 20160310535
    Abstract: The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
    Type: Application
    Filed: July 1, 2016
    Publication date: October 27, 2016
    Inventors: Mohamed Attawia, Thomas M. DiMauro, Hassan Serhan, Sudhakar Kadiyala, David Urbahns, Scott Bruder
  • Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines
    Publication number: 20160310537
    Abstract: The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
    Type: Application
    Filed: July 1, 2016
    Publication date: October 27, 2016
    Inventors: Mohamed Attawia, Thomas M. DiMauro, Hassan Serhan, Sudhakar Kadiyala, David Urbahns, Scott Bruder
  • Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines
    Publication number: 20160310539
    Abstract: The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
    Type: Application
    Filed: July 1, 2016
    Publication date: October 27, 2016
    Inventors: Mohamed Attawia, Thomas M. DiMauro, Hassan Serhan, Sudhakar Kadiyala, David Urbahns, Scott Bruder
  • Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines
    Publication number: 20160310536
    Abstract: The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
    Type: Application
    Filed: July 1, 2016
    Publication date: October 27, 2016
    Inventors: Mohamed Attawia, Thomas M. DiMauro, Hassan Serhan, Sudhakar Kadiyala, David Urbahns, Scott Bruder
  • Transdiscal Administration Of Specific Inhibitors Of Pro-Inflammatory Cytokines
    Publication number: 20160310538
    Abstract: The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
    Type: Application
    Filed: July 1, 2016
    Publication date: October 27, 2016
    Inventors: Mohamed Attawia, Thomas M. DiMauro, Hassan Serhan, Sudhakar Kadiyala, David Urbahns, Scott Bruder
  • TRANSDISCAL ADMINISTRATION OF SPECIFIC INHIBITORS OF PRO-INFLAMMATORY CYTOKINES
    Publication number: 20160228558
    Abstract: The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
    Type: Application
    Filed: April 15, 2016
    Publication date: August 11, 2016
    Inventors: Mohamed Attawia, Thomas M. DiMauro, Hassan Serhan, Sudhakar Kadiyala, David Urbahns, Scott Bruder
  • Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
    Patent number: 8895540
    Abstract: This invention relates to local administration of a bone-forming agent and at least one anti-resorptive agent to treat osteoporosis and related disorders.
    Type: Grant
    Filed: November 26, 2003
    Date of Patent: November 25, 2014
    Assignee: DePuy Synthes Products, LLC
    Inventors: Thomas M. DiMauro, Mohamed Attawia, Hassan Serhan, Melissa Grace, Michael Slivka, Thomas G. Ferro, Vivek N. Shenoy, Alonzo D. Cook, Scott Bruder
  • Transdiscal administration of anti-TNF? antibodies and growth differentiation factors
    Patent number: 8877193
    Abstract: The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
    Type: Grant
    Filed: November 5, 2008
    Date of Patent: November 4, 2014
    Assignee: DePuy Synthes Products, LLC.
    Inventors: Hassan Serhan, Mohamed Attawia, Thomas M. DiMauro, Sudhakar Kadiyala, David Urbahns, Scott Bruder
  • Transdiscal Administration of Specific Inhibitors of Pro-Inflammatory Cytokines
    Publication number: 20140199322
    Abstract: The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
    Type: Application
    Filed: March 20, 2014
    Publication date: July 17, 2014
    Applicant: DePuy Synthes Products, LLC
    Inventors: Mohamed Attawia, Thomas M. DiMauro, Hassan Serhan, Sudhakar Kadiyala, David Urbahns, Scott Bruder
  • Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
    Patent number: 8728523
    Abstract: The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
    Type: Grant
    Filed: November 7, 2008
    Date of Patent: May 20, 2014
    Assignee: DePuy Synthes Products, LLC
    Inventors: Mohamed Attawia, Thomas M. DiMauro, Hassan Serhan, Sudhakar Kadiyala, David Urbahns, Scott Bruder
  • Trans-capsular administration of high specificity cytokine inhibitors into orthopedic joints
    Patent number: 8361467
    Abstract: The present invention relates to trans-capsularly administering into a diseased joint a high specificity antagonist selected from the group consisting of: i) an inhibitor of a pro-inflammatory interleukin; ii) an inhibitor of TNF-? synthesis; iii) an inhibitor of membrane-bound TNF-?; iv) an inhibitor of a natural receptor of TNF-?; v) an inhibitor of NO synthase, vi) an inhibitor of PLA2 enzyme; vii) an anti-proliferative agent; viii) an anti-oxidant; ix) an apoptosis inhibitor selected from the group consisting of EPO mimetic peptides, EPO mimetibodies, IGF-I, IGF-II, and caspase inhibitors, and x) an inhibitor of MMPs; and xi) an inhibitor of p38 kinase.
    Type: Grant
    Filed: July 30, 2003
    Date of Patent: January 29, 2013
    Assignee: DePuy Spine, Inc.
    Inventors: Thomas M. DiMauro, Mohamed Attawia, Hassan Serhan, Martin A. Reynolds, Melissa Grace, Sudhakar Kadiyala, David Urbahns, Scott Bruder, Gregory Collins, Laura J. Brown, Jeff Geesin, Pamela L. Plouhar, Catherine Smith, John Siekierka
  • Autologous bone graft material
    Patent number: 8137408
    Abstract: This invention relates to a musculoskeletogenic MSG graft composite made from whole bone marrow aspirate BMA having native levels of musculoskeletal progenitor cells MSPCs, comprising: a) a suspension of fractionated BMA comprising: i) MSPCs present at a level greater than their native level in whole BMA, and ii) red blood cells RBCs present at a level less than their native level in whole BMA, and b) a porous sterile matrix having an average pore size of at least 20 ?m.
    Type: Grant
    Filed: October 30, 2007
    Date of Patent: March 20, 2012
    Assignee: DePuy Spine, Inc.
    Inventors: Sudhakar Kadiyala, Scott Bruder
  • Transdiscal administration of specific inhibitors of pro-inflammatory cytokines
    Publication number: 20090175943
    Abstract: The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
    Type: Application
    Filed: November 7, 2008
    Publication date: July 9, 2009
    Inventors: Mohamed Attawia, Thomas M. DiMauro, Hassan Serhan, Sudhakar Kadiyala, David Urbahns, Scott Bruder
  • Transdiscal administration of cycline compounds
    Patent number: 7553827
    Abstract: The present invention relates to injecting a cycline compound into a diseased intervertebral disc.
    Type: Grant
    Filed: August 13, 2003
    Date of Patent: June 30, 2009
    Assignee: DePuy Spine, Inc.
    Inventors: Mohamed Attawia, Thomas M. DiMauro, Hassan Serhan, Sudhakar Kadiyala, David Urbahns, Scott Bruder, Laura J. Brown, Jeffrey C. Geesin
  • Transdiscal administration of anti-TNFalpha antibodies and growth differentiation factors
    Publication number: 20090155364
    Abstract: The present invention relates to injecting a high specificity cytokine antagonist into a diseased intervertebral disc.
    Type: Application
    Filed: November 5, 2008
    Publication date: June 18, 2009
    Inventors: Hassan Serhan, Mohamed Attawia, Thomas M. DiMauro, Sudhakar Kadiyala, David Urbahns, Scott Bruder
  • Transdiscal administration of high affinity anti-MMP inhibitors
    Patent number: 7429378
    Abstract: The present invention relates to injecting a high affinity antagonist of MMPs into a diseased intervertebral disc.
    Type: Grant
    Filed: June 30, 2003
    Date of Patent: September 30, 2008
    Assignee: DePuy Spine, Inc.
    Inventors: Hassan Serhan, Thomas M. DiMauro, Mohamed Attawia, Sudhakar Kadiyala, David Urbahns, Scott Bruder, Laura J. Brown, Jeffrey C. Geesin
  • Local intraosseous administration of bone forming agents and anti-resorptive agents, and devices therefor
    Patent number: RE49219
    Abstract: This invention relates to local administration of a bone-forming agent and at least one anti-resorptive agent to treat osteoporosis and related disorders.
    Type: Grant
    Filed: November 21, 2016
    Date of Patent: September 27, 2022
    Assignee: DePuy Synthes Products, Inc.
    Inventors: Thomas M. DiMauro, Mohamed Attawia, Hassan Serhan, Melissa Grace, Michael Slivka, Thomas G. Ferro, Vivek N. Shenoy, Alonzo D. Cook, Scott Bruder